The Valley Desk

NCT06943755 · Interventional trial

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Overall registry status Recruiting

Phase 2 · Phase 3

Conditions Extra-Pancreatic Neuroendocrine Tumor (epNET), Pancreatic Neuroendocrine Tumor (pNET)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov